Prospective Study of the Variation in Uterine Flexion Angle Before and After Voiding in Parous Women.
Launched by UNIVERSITY HOSPITAL, BREST · Jul 17, 2025
Trial Information
Current as of November 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how the angle of the uterus changes before and after urinating in women who have given birth (called parous women). Understanding this angle is important because it can affect how easy or difficult it is to insert an intrauterine device (IUD), a common form of birth control. The study will also explore how a simple breathing technique called the Valsalva maneuver—where you gently bear down as if straining—might help make certain gynecological procedures easier by improving the position of the cervix.
Women who are eligible to join are adults who have had at least one child, are not pregnant, and are able to participate in the study. Women over 65 years old or those with recent childbirth, certain surgeries, or other specific health conditions will not be able to join. Participants will be asked about their bladder filling and may be guided through the Valsalva maneuver during the study. This research is not yet recruiting but aims to help improve the comfort and success of procedures like IUD insertion for women in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adult women
- • Parous
- • Experiencing the need to urinate
- • Affiliated with a social security scheme or equivalent
- Exclusion Criteria:
- • Pregnant women
- • Desire for pregnancy with ongoing conception process
- • Age \> 65 years
- • History of hysterectomy
- • History of conization
- • Childbirth \< 6 months
- • Irrepressible need to urinate
- • Inability or refusal to participate in the study
About University Hospital, Brest
The University Hospital of Brest is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. With a strong emphasis on interdisciplinary collaboration, the hospital serves as a hub for cutting-edge clinical trials aimed at improving treatment outcomes across various medical specialties. Leveraging its robust academic affiliations and state-of-the-art facilities, the University Hospital of Brest is committed to fostering scientific discovery and enhancing the quality of life for patients through evidence-based practices and pioneering research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brest, Finistere, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported